The Glucocorticoid Taper: A Primer for the Clinicians

Area of Science:

• Endocrinology
• Immunology
• Pharmacology

Background:

• Glucocorticoids (GCs) effectively treat inflammatory/immunological disorders but carry risks of significant side effects with prolonged or high-dose use.
• GC therapy can suppress the endogenous hypothalamic-pituitary-adrenal (HPA) axis, leading to adrenal insufficiency (AI) upon abrupt cessation.
• Minimizing GC dosage and duration is crucial to mitigate adverse effects.

Purpose of the Study:

• To outline optimal strategies for tapering glucocorticoid (GC) therapy.
• To ensure safe discontinuation of GCs while preserving hypothalamic-pituitary-adrenal (HPA) axis function.
• To prevent GC-induced adrenal insufficiency (AI) and disease flares.

Main Methods:

• Gradual reduction of GC dosage from moderate-to-high levels to near-physiological doses, monitoring for disease reactivation.
• Slower tapering with longer intervals once near physiological doses are achieved to facilitate HPA axis recovery.
• Consideration of short- or intermediate-acting GC preparations (e.g., hydrocortisone, prednisolone) in morning physiological doses.
• Potential use of HPA axis function testing (basal/stimulated serum cortisol) in high-risk cases or if AI symptoms emerge.
• Patient education on stress-dose GC adjustments and the importance of carrying a steroid alert card.

Main Results:

• Tapering allows for HPA axis recovery and minimizes AI risk.
• Rapid tapering to physiological doses is feasible, followed by slower reduction.
• HPA axis recovery duration correlates with the prior suppression period; longer suppression necessitates slower tapering.
• HPA axis testing may guide further tapering decisions.
• Patient preparedness for medical/surgical stress is vital to prevent adrenal crisis.

Conclusions:

• GC tapering is essential for safe withdrawal and HPA axis recovery.
• Tailored tapering schedules, considering prior GC exposure, are necessary.
• Monitoring for AI and patient education are critical components of GC management.
• Individualized management, potentially including HPA axis testing, ensures optimal outcomes.